Literature DB >> 19895518

Liver resection using heat coagulative necrosis: indications and limits of a new method.

Gregor A Stavrou1, Marcello Donati, Nils R Fruehauf, Peer Flemming, Karl-Juergen Oldhafer.   

Abstract

BACKGROUND: A new approach towards achieving bloodless liver resection is the use of heat coagulative necrosis. The latest stage of this technique is a four-probe device (Habib Sealer), which we used for a variety of resections to find the best indications for the method.
METHODS: Between 2005 and 2006 we performed 28 liver resections in 20 consecutive patients. The most common indication was metastatic colorectal cancer (75%). We treated a heterogeneous patient collective in terms of tumour localization and extent of resection. Resection was performed after creating a necrotic zone. The device achieved an area of coagulation of 1-cm width in which even larger vessels and bile ducts were safely sealed.
RESULTS: Operative spectrum covered atypical resections (8), one- or bisegmentectomies at different locations (15), hemihepatectomies (4) and one extended right hepatectomy. With one exception intra-operative blood loss was lower than 100 mL. Four patients (20%) developed operation-related complications comprising abscess formation at the resection site. Follow-up shows tumour-free survival for 13 of 18 patients 12 months after resection.
CONCLUSION: Liver resection using the sealer device seems safe. In proximity of hilar structures or large vessels the method is not favourable for the fear of thermal damage. Extended resections are possible but not parenchyma saving. Good indications are atypical (deep) resections - especially in Segment IVb.

Entities:  

Mesh:

Year:  2009        PMID: 19895518     DOI: 10.1111/j.1445-2197.2009.05017.x

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  1 in total

1.  Techniques of radiofrequency-assisted precoagulation in laparoscopic liver resection.

Authors:  Hizir Yakup Akyildiz; Gareth Morris-Stiff; Federico Aucejo; John Fung; Eren Berber
Journal:  Surg Endosc       Date:  2010-09-16       Impact factor: 4.584

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.